Enliven Therapeutics, Inc. (ELVN) SEC Filings — 2025
10 SEC filings for Enliven Therapeutics, Inc. (ELVN) in 2025.
Filings
- Enliven Therapeutics Announces Executive and Board Changes — 8-K · Dec 11, 2025
- Enliven Therapeutics, Inc. 8-K/A Filing — 8-K/A · Nov 13, 2025
- Enliven Narrows Q3 Loss, Boosts Cash with $216M Public Offering — 10-Q · Nov 12, 2025
- Enliven Therapeutics Files 8-K on Financials — 8-K · Aug 13, 2025
- Enliven Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 25, 2025
- Enliven Therapeutics Files 8-K for Material Agreement — 8-K · Jun 16, 2025
- Enliven Therapeutics Files 8-K — 8-K · Jun 13, 2025
- Enliven Therapeutics Files Q1 2025 10-Q — 10-Q · May 14, 2025
- Enliven Therapeutics Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
- Enliven Therapeutics Files 2024 10-K — 10-K · Mar 13, 2025